Literature DB >> 32454303

Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: A systematic review and dose-response meta-analysis of cohort studies among four million participants.

Jamal Rahmani1, Arezoo Haghighian Roudsari2, Hiba Bawadi3, Jacqueline Thompson4, Razieh Khalooei Fard5, Cain Clark6, Paul M Ryan7, Marjan Ajami2, Fatemeh Rahimi Sakak5, Ammar Salehisahlabadi5, Hebatullah M Abdulazeem8, Mohammad Reza Jamali9, Jalaledin Mirzay Razaz10.   

Abstract

BACKGROUND: The relationship between body mass index (BMI) and risk of venous thromboembolism (VTE) and pulmonary embolism (PE) is a controversial issue. This dose-response meta-analysis was performed to investigate the association between BMI and risk of VTE and PE incidence based on cohort studies.
METHOD: A comprehensive systematic search was conducted up to August 2019 in MEDLINE/PubMed, SCOPUS, and Cochrane. DerSimonian and Laird random-effects models were run to estimate combined hazard ratios (HRs) with 95% confidence intervals (CIs). Dose-response analysis was also carried out based on BMI values.
RESULTS: Eleven articles with 16 arms and 3,910,747 participants were eligible for inclusion in this systematic review and meta-analysis. Pooled results showed a positive association between BMI and risk of VTE in the obese participants compared to participants classified in the normal BMI category (HR: 1.62, 95% CI: 1.29-2.04, I2 = 95%). Furthermore, results showed a significant association between lower BMI (underweight versus normal BMI category) and reduced risk of PE (HR: 0.80, 95% CI: 0.70-0.92, I2 = 9%) and higher risk of PE in obese versus normal BMI participants (HR: 2.24, 95% CI: 1.93-2.60, I2 = 0%). There was a significant linear relationship between BMI and risk of VTE (p < 0.001) and PE (p < 0.001).
CONCLUSIONS: This systematic review and dose-response meta-analysis with 3,910,747 participants highlights obesity as a significant risk factor related to the incidence of VTE and PE.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body mass index; Pulmonary embolism; Venous thromboembolism

Mesh:

Year:  2020        PMID: 32454303     DOI: 10.1016/j.thromres.2020.05.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

Review 1.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

2.  Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.

Authors:  Tobias Frischmuth; Kristian Hindberg; Pål Aukrust; Thor Ueland; Sigrid K Braekkan; John-Bjarne Hansen; Vânia M Morelli
Journal:  J Thromb Haemost       Date:  2022-03-25       Impact factor: 16.036

3.  Obesity increases cardiovascular mortality in patients with HFmrEF.

Authors:  Zhican Liu; Yiqun Peng; Wenjiao Zhao; Yunlong Zhu; Mingxin Wu; Haobo Huang; Ke Peng; Lingling Zhang; Sihao Chen; Xin Peng; Na Li; Hui Zhang; Yuying Zhou; Yongliang Chen; Sha Xiao; Jie Fan; Jianping Zeng
Journal:  Front Cardiovasc Med       Date:  2022-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.